Skip to main navigation Skip to search Skip to main content

Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents

  • Renu John
  • , Freddy T. Nguyen
  • , Kenneth J. Kolbeck
  • , Eric J. Chaney
  • , Marina Marjanovic
  • , Kenneth S. Suslick
  • , Stephen A. Boppart

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: In this study, protein-shell microspheres filled with a suspension of iron oxide nanoparticles in oil are demonstrated as multimodal contrast agents in magnetic resonance imaging (MRI), magnetomotive optical coherence tomography (MM-OCT), and ultrasound imaging. The development, characterization, and use of multifunctional multimodal microspheres are described for targeted contrast and therapeutic applications. Procedures: A preclinical rat model was used to demonstrate the feasibility of the multimodal multifunctional microspheres as contrast agents in ultrasound, MM-OCT and MRI. Microspheres were functionalized with the RGD peptide ligand, which is targeted to α vβ 3 integrin receptors that are over-expressed in tumors and atherosclerotic lesions. Results: These microspheres, which contain iron oxide nanoparticles in their cores, can be modulated externally using a magnetic field to create dynamic contrast in MM-OCT. With the presence of iron oxide nanoparticles, these agents also show significant negative T2 contrast in MRI. Using ultrasound B-mode imaging at a frequency of 30 MHz, a marked enhancement of scatter intensity from in vivo rat mammary tumor tissue was observed for these targeted protein microspheres. Conclusions: Preliminary results demonstrate multimodal contrast-enhanced imaging of these functionalized microsphere agents with MRI, MM-OCT, ultrasound imaging, and fluorescence microscopy, including in vivo tracking of the dynamics of these microspheres in real-time using a high-frequency ultrasound imaging system. These targeted oil-filled protein microspheres with the capacity for high drug-delivery loads offer the potential for local delivery of lipophilic drugs under image guidance.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalMolecular Imaging and Biology
Volume14
Issue number1
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Funding

Acknowledgements. This research was supported in part by grants from the National Institutes of Health (Roadmap Initiative, NIBIB R21 EB005321, NIBIB R01 EB009073, and NCI RC1 CA147096).

FundersFunder number
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health
National Institute of Health-National Cancer InstituteRC1 CA147096
National Institute of Biomedical Imaging and BioengineeringR01 EB009073, R21EB005321

    Keywords

    • Alpha(v) beta(3) targeting
    • Contrast agents
    • Iron oxide
    • Magnetic resonance imaging
    • Magnetomotive optical coherence tomography
    • Protein microspheres
    • RGD peptide
    • Ultrasound imaging

    ASJC Scopus subject areas

    • Oncology
    • Radiology Nuclear Medicine and imaging
    • Cancer Research

    Fingerprint

    Dive into the research topics of 'Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents'. Together they form a unique fingerprint.

    Cite this